167
Participants
Start Date
May 7, 2018
Primary Completion Date
January 31, 2021
Study Completion Date
January 31, 2021
Mycophenolate Mofetil
oral tablets
Azathioprine
oral tablet
University at Buffalo, SUNY, Buffalo
University of Rochester Medical Center, Rochester
University of Pittsburgh, Pittsburgh
University of Pennsylvania, Philadelphia
University of North Carolina at Chapel Hill, Chapel Hill
Duke University, Durham
Medical University of South Carolina, Charleston
Unversity of Miami, Miami
Cleveland Clinic, Cleveland
Rush University Medical Center, Chicago
Ochsner Clinic Foundation, New Orleans
Stanford University, Palo Alto
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
St. Elizabeth's Medical Center, Brighton
University of Vermont - Larner College of Medicine, Burlington
University of Alberta Hospital, Faculty of Medicine, Edmonton
London Health Sciences Centre, London
Lead Sponsor
Beth Israel Deaconess Medical Center
OTHER
Patient-Centered Outcomes Research Institute
OTHER
Duke University
OTHER